Health Care: Drugs

Discovery Laboratories Inc. (DSCO: NASDAQ)

$1.9 -0.06 | -3.06%
04/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.96
52 Week High 3.05
52 Week Low 1.50
Avg. Daily Vol. (Mil) 0.67
Beta (3 year) 1.41
Share Related Items
Mkt Cap (Mil) 166.01
Shares Out (Mil) 84.70
Float (Mil) 36.97
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.30
Current Ratio 7.40
LT Debt/ Equity 0.31
Total Debt / Equity 0.32
Valuation Ratios
Price Earnings n.a.
Price/Sales 427.85
Price/Book 2.84
Price/Cash Flow -3.80
Per Share Data
Earnings -0.82
Sales 0.00
Book Value 0.69
Cash Flow -0.52
Business Summary
Discovery Laboratories, Inc. is engaged in the development of Surfactant Replacement Therapies (SRT) to treat respiratory disorders and diseases for which there frequently are few or no approved therapies.
General Information
2600 Kelly Road
Suite 100
Warrington, PA 18976-3622
www.discoverylabs.com
Industry : Drugs
Sector: Health Care
Employees: 126
CEO: John G. Cooper
Short Interest
Current Month (Mil) 4.14
Previous Month (Mil) 3.93
Short Interest Ratio (Days) 5.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -50.60
Return on Investments -58.80
Profitability
Gross Margin -33.20
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with DSCO

Latest DSCO Headlines from TheStreet

More Financial News for DSCO

Press Releases for DSCO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter